Evolv launches oral hair growth supplement containing EV2 Peptide

Supplement brand Evolv, which pioneered the first orally bioavailable GLP-1 biomimetic peptide designed to support appetite regulation and metabolic health, has introduced Evolv Grow for hair growth support. Formulated for men and women, the supplement features the brand’s proprietary EV2 Peptide — a custom molecule bioengineered to mimic the natural hair-growth pathways of GHK-Cu copper peptides. 

Evolv Grow claims to support hair density, follicular activity, and visible regrowth through a proprietary oral biomimetic platform.

“Hair loss affects millions of people, yet innovation in the category has remained surprisingly limited,” says Dr. Cory Henderson, co-founder of Evolv.

“We created Evolv Grow to bridge the gap between ineffective supplements and more invasive interventions by developing a science-first solution designed to work with the body’s natural biology. Our goal is to make advanced hair growth support more accessible to consumers seeking meaningful, long-term results.”

Hair density for men and women

Available in two targeted formulas, Evolv Grow addresses the unique biological patterns associated with male and female hair thinning while sharing the same EV2 Peptide technology platform.

To support hair density, EV2 Peptide is a proprietary blend made using Evolv’s Cu Peptide Mimetic technology, which fuses marine collagen-derived peptides and bioactive copper with compounds designed to replicate GHK-Cu.

Evolv Grow for him is designed for men experiencing early to moderate thinning at the crown and hairline and supports hair regrowth, density, and scalp coverage without hormones. Evolv Grow for her is formulated for women experiencing thinning around the part, temples, or through diffuse shedding and is designed to support growth, volume, density, and reduced breakage.

Study findings

Evolv Grow is backed by a 12-week, randomized, placebo-controlled study of 60 participants, with measurements collected every two weeks by an independent third-party research organization.

Day 14 interim results showed 39% greater hair growth among those taking the supplement compared to placebo, as well as four times greater improvement in hair thickness.

Results also demonstrated an average of 1.11 cm of hair growth and an average increase of 0.40 cm in hair thickness. The ongoing study continues to evaluate hair growth, density, shedding, and overall hair quality throughout the 12-week period.

‘Consumers increasingly view hair health as part of a broader wellness routine rather than a standalone beauty concern,” says Becca McCarthy, CEO and co-founder of Evolv.

“As conversations around longevity, preventative wellness, and performance continue to evolve, we’re seeing growing demand for science-backed solutions that fit seamlessly into everyday life. Evolv Grow was created to meet that need with a non-hormonal, orally delivered approach designed to support healthier, fuller-looking hair from within.”

Peptide pipeline

Peptides continue to feature across new product development, highlighted for various end targets as well as synergies with conventional ingredients like whey protein.

Last month, Darling Ingredients brand Rousselot received a US patent for its collagen peptide ingredient Nextida GC. The ingredient is developed to support blood sugar levels after meals, and the patent protects the use of Nextida as a dietary supplement ingredient and its production process.

Earlier this year, Gelita introduced Curaderm, a bioactive collagen peptide to support skin healing, atopic-prone skin, and gum health. The company says it is the first collagen peptide with scientifically substantiated results that promise evidence-based positioning for skin and gum care concepts.